Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Fuji
Citi
Queensland Health
US Department of Justice
Daiichi Sankyo
Harvard Business School
Merck
Express Scripts
Boehringer Ingelheim

Generated: February 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 065044

« Back to Dashboard

NDA 065044 describes CYCLOSPORINE, which is a drug marketed by Apotex, Ivax Sub Teva Pharms, Mayne Pharma, Sandoz, Luitpold, West-ward Pharms Int, Abbvie, Apotex Inc, and Wockhardt Bio Ag, and is included in eleven NDAs. It is available from eleven suppliers. Additional details are available on the CYCLOSPORINE profile page.

The generic ingredient in CYCLOSPORINE is cyclosporine. There are seventeen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the cyclosporine profile page.
Summary for 065044
Tradename:CYCLOSPORINE
Applicant:Mayne Pharma
Ingredient:cyclosporine
Patents:0
Therapeutic Class:Immunological Agents
Ophthalmic Agents
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 065044
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CYCLOSPORINE cyclosporine CAPSULE;ORAL 065044 ANDA Actavis Pharma, Inc. 0591-2222 N 0591-2222-15
CYCLOSPORINE cyclosporine CAPSULE;ORAL 065044 ANDA Actavis Pharma, Inc. 0591-2223 N 0591-2223-15

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength100MG
Approval Date:Dec 20, 2000TE:AB1RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength25MG
Approval Date:Dec 20, 2000TE:AB1RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Chubb
Farmers Insurance
Teva
Fish and Richardson
Healthtrust
US Department of Justice
Daiichi Sankyo
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot